Citywire for Financial Professionals

Syncona (Ordinary Share) SYNC

Sector Specialist: Biotechnology/Life Sciences

Register or Sign in to receive email alerts for items in your favourites whenever we write about them

Add to Virtual Portfolio | Print page

Estimated NAV

157.00

Share Price

 

Total Returns on £1000 over 

Fund / Benchmark Total returns(%)
Syncona (Ordinary Share) Price 61.83%
Syncona (Ordinary Share) NAV 43.67%
FTSE World 51.57%
Total Returns on £1000

Discount / Premium Movement

Discount / Premium Movement

Shares

Share Type Yesterday's
Closing Price
Discount / Premium Diluted NAV Gearing Dividend
Est Last
Ordinary Share 183.9 17.3% 157.00 156.00
29 Sep
100% 1.20%

Discrete performance % over

Fund / BenchmarkDec '14
Nov '15
Dec '15
Nov '16
Dec '16
Nov '17
Syncona (Ordinary Share) Price10.180.8545.65
Syncona (Ordinary Share) NAV7.217.6624.47
FTSE World1.9828.2315.91

Discrete performance over

Discrete Performance

Top 10 Holdings

Polygon European Equity Opportunity Fund 4.95%
Polar Capital Japan Alpha Fund 4.62%
The SFP Value Realization Fund 4.19%
Polar UK Absolute Equity Fund 3.98%
Majedie Asset UK Equity 3.87%
Parity Value Fund 3.87%
Maga Smaller Companies Fund 3.44%
AKO Global UCITS Fund 3.33%
Sinfonietta Fund 3.01%
Portland Hill 2.90%

Sectors weighting

Life Science 32.00%
Equity Hedge 26.00%
Equity Non- Hedge 17.00%
Cash/Cash Equivalent 7.00%
Macro 6.00%
Credit 6.00%
Unlisted Equities 3.00%
Fixed Interest 2.00%
Infrastructure 1.00%
  • Investment trust info:

  • Sector Sector Specialist: Biotechnology/Life Sciences
  • Launch Date 26 Oct 2012
  • Currency  
  • Domicile Guernsey
  • Share Price  
  • Share Type Ordinary Share
  • TIDM SYNC
  • ISIN GG00B8P59C08
  • Shares Issued (M) 660
  • Market Capital (£M) 1213.65
  • Gross Assets (£M) 1034.61
  • Net Assets (£M) 1034.61
  • TER (%) 1.27
  • Historic Dividend Yield (%) 1.20
  • Last AGM 08 Sep 2017
  • Next AGM 10 Sep 2018
  • Last Annual Report Date 01 Aug 2016
  • Next due Report Date 31 Mar 2017
  • Next due Report Type A/R
  • Objective:

  • To deliver superior returns from investments in life science businesses, leading long-only and alternative investment funds across multiple asset classes.
  • Management Group(s):

  • BACIT Investments LP
  • Managed by:

  • Fenella Dernie Start: 26 Oct 2012
  • John McDonald Start: 26 Oct 2012
  • Management Contract & Fees:

    The Group's administrator is Northern Trust International Fund Administration Services (Guernsey) Limited. Following the implementation of the revised Administration Agreement on 1 May 2014, the Administrator is entitled to receive an annual fee of up to 6 basis points of the NAV of the Company, calculated monthly in arrears, subject to a minimum fee of 120,000 per annum. Prior to 1 May 2014, the Administrator was entitled to receive an annual fee of up to 7.5 basis points of the NAV of the Company, calculated monthly in arrears, subject to a minimum fee of 120,000 per annum.

Sorry, this link is not
quite ready yet